•
Jun 30, 2021

Seres Therapeutics Q2 2021 Earnings Report

Total Revenue
$5.26M
Previous year: $6.05M
-12.9%
EPS
-$0.53
Previous year: -$0.28
+89.3%
Gross Profit
-$30.7M
Cash and Equivalents
$74M
Free Cash Flow
-$42.2M
Total Assets
$270M

Seres Therapeutics

Seres Therapeutics